Fabienne Baffert

Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts

Tetsuichiro Inai, Michael R. Mancuso, Hiroya Hashizume et al. · American Journal Of Pathology · 2004 · 763 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling

Fabienne Baffert, Tom Le, Barbara Sennino et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2005 · 371 citations

Life Sciences, Cell Biology, Molecular Biology +14

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition

Oliver Weigert, Andrew A. Lane, Liat Bird et al. · The Journal of Experimental Medicine · 2012 · 162 citations · Full text

Medicine, Oncology, Pharmacology +14

CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms

Sara C. Meyer, Matthew D. Keller, Sophia Chiu et al. · Cancer Cell · 2015 · 155 citations

Medicine, Pharmacology, Pharmacotherapy +13

Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules

Fabienne Baffert, Tom Le, Gavin Thurston et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2005 · 135 citations

Life Sciences, Cell Biology, Pharmacology +17